Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Human seroprevalence of rift valley fever in the Timbuktu region, Mali, 2021

Breadcrumb

  • Home
  • Human seroprevalence of rift valley fever in the Timbuktu region, Mali, 2021

Issa DIARRA 1, *, Abdourahamane TRAORE 1, Nazli AYHAN 2, Laurence THIRION 2, Mady CISSOKO 3, Seydou ARAMA 3, Moussa Hama SANKARE 3, Mouhamed THIERO 4, Bakary KOITA 5, Ami DIAKITE 1, Adama CISSE 2, Ousmane MAIGA 6 and Xavier de Lamballerie 2

1 Laboratoire de Biologie Moléculaire Appliquée (LBMA), Faculté de Pharmacie, Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Mali.
2 Unité des Virus Émergents (UVE: Aix-Marseille Univ – IRD 190 – Inserm 1207 – IHU Méditerranée Infection), Marseille, France. 
3 Direction Régionale de la Santé de Tombouctou, Mali.
4 Hôpital NIANAKORO FOMBA de Ségou, Mali.
5 Infirmerie de Génie Militaire, Direction Centrale du Service de Santé des Armées, Bamako, Mali.
6 Universités des Sciences des Techniques et des Technologie de Bamako, Mali.
 

Research Article

World Journal of Biology Pharmacy and Health Sciences, 2025, 24(02), 266-273

Article DOI: 10.30574/wjbphs.2025.24.2.0997

DOI url: https://doi.org/10.30574/wjbphs.2025.24.2.0997

Received on 29 September 2025; revised on 05 November 2025; accepted on 08 November 2025

Rift Valley fever (RVF) is a zoonotic disease with a human mortality rate of up to 50%. Its prevalence in cattle in Timbuktu, in northern Mali, has been estimated at 10%. In this region, close contact between humans and animals increases the likelihood of exposure to the Rift Valley fever virus (RVFV). Despite this potential risk, no human epidemic has been reported in Timbuktu to date. 
To address this gap, we conducted a population-based study to estimate the seroprevalence of RVF in five districts of the Timbuktu region. Using the competitive ELISA technique, we found an overall human seroprevalence of RVF of 10.7% (95% CI: 8.8% - 12.8%) among 983 volunteers, closely like seroprevalence observed in cattle. These findings clearly demonstrated the circulation of the RVFV in the human population in all districts of the Timbuktu region and highlight the need to strengthen public health strategies to better prepare for potential future outbreaks.
 

Seroprevalence; Rift Valley Fever; Timbuktu; Mali

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2025-0997.pdf

Preview Article PDF

Issa DIARRA, Abdourahamane TRAORE, Nazli AYHAN, Laurence THIRION, Mady CISSOKO, Seydou ARAMA, Moussa Hama SANKARE, Mouhamed THIERO, Bakary KOITA, Ami DIAKITE, Adama CISSE, Ousmane MAIGA and Xavier de Lamballerie. Human seroprevalence of rift valley fever in the Timbuktu region, Mali, 2021. World Journal of Biology Pharmacy and Health Sciences, 2025, 24(02), 266-273. Article DOI: https://doi.org/10.30574/wjbphs.2025.24.2.0997.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution